Thyroid disease

Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study

J Clin Endocrinol MetabPublished Retrospective cohort study

Main finding · In-hospital mortalityResult — go to the resultOdds ratio 0.91 95% CI 0.62–1.34

Authors' conclusion

Our findings suggest that KI may reduce in-hospital mortality among patients hospitalized for thyroid storm with Graves' disease.

Study context

Population
Patients hospitalized with thyroid storm, Japanese Diagnosis Procedure Combination database, July 2010–March 2022
Participants
3,188 eligible patients
Exposure
KI within 2 days of admission vs no KI
  • KIn = 2,350
  • non-KIn = 838reference
Outcome
In-hospital mortality
Methodological detailsobservational, nationwide inpatient database, prespecified subgroup analyses by Graves' disease diagnosis
  • Observational
  • Nationwide inpatient database
  • Prespecified subgroup analyses by Graves' disease diagnosis

Main finding

As reported in the abstract

Odds ratio

0.91

95% CI 0.62–1.34

Events by group

KIvs non-KI
OR 0.91 (95% CI 0.62–1.34)

Observational data: associations, not effects.

Further findings

OutcomeEstimate
In-hospital mortality, patients with GD diagnosisPrespecified subgroup analysisOR 0.46 (95% CI 0.25–0.88)
In-hospital mortality, patients without GD diagnosisPrespecified subgroup analysisOR 1.11 (95% CI 0.67–1.85)
LOSShorter with KIsubdistribution HR 1.15 (95% CI 1.05–1.27)
Total hospitalization costsOR 0.92 (95% CI 0.85–1.00)

Original publication

Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study. J Clin Endocrinol Metab. Published 28 March 2024. doi:10.1210/clinem/dgae187

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.